BIOTECHNOLOGY VALUE FUND L P
Related Filers (223)
- BVF INC/IL (487)
- BVF PARTNERS L P/IL (487)
- BIOTECHNOLOGY VALUE FUND II LP (483)
- LAMPERT MARK N (330)
- BVF INVESTMENTS LLC (266)
- BVF Partners OS Ltd. (207)
- Biotechnology Value Trading Fund OS LP (207)
- BVF GP HOLDINGS LLC (125)
- BVF I GP LLC (125)
- BVF II GP LLC (125)
- ARQULE INC (58)
- LIGAND PHARMACEUTICALS INC (45)
- NEUROCRINE BIOSCIENCES INC (42)
- AVIGEN INC \DE (42)
- XOMA Corp (40)
- INFINITY PHARMACEUTICALS, INC. (32)
- CATALYST BIOSCIENCES, INC. (31)
- CORVAS INTERNATIONAL INC (30)
- Merus N.V. (27)
- FIVE PRIME THERAPEUTICS, INC. (26)
- REPLIGEN CORP (25)
- NEUROGEN CORP (25)
- Cascadian Therapeutics, Inc. (25)
- CYTOKINETICS INC (25)
- Xenon Pharmaceuticals Inc. (24)
- Zalicus Inc. (23)
- Celera CORP (23)
- CTI BIOPHARMA CORP (23)
- ChemoCentryx, Inc. (23)
- NPS PHARMACEUTICALS INC (22)
- Capstone Therapeutics Corp. (22)
- Kymera Therapeutics, Inc. (21)
- Rain Oncology Inc. (21)
- ADVANCED MAGNETICS INC (20)
- FLAMEL TECHNOLOGIES SA (17)
- ARENA PHARMACEUTICALS INC (17)
- ADOLOR CORP (17)
- CONCERT PHARMACEUTICALS, INC. (17)
- PIERIS PHARMACEUTICALS, INC. (17)
- ARRAY BIOPHARMA INC (16)
- Repare Therapeutics Inc. (16)
- DYNAVAX TECHNOLOGIES CORP (15)
- ALPINE IMMUNE SCIENCES, INC. (14)
- GLYCOMIMETICS INC (14)
- IDEAYA Biosciences, Inc. (14)
- SYNAPTIC PHARMACEUTICAL CORP (13)
- AEOLUS PHARMACEUTICALS, INC. (13)
- Eledon Pharmaceuticals, Inc. (13)
- Calithera Biosciences, Inc. (13)
- SGX PHARMACEUTICALS, INC. (12)
- QLT INC/BC (11)
- Astex Pharmaceuticals, Inc (11)
- Regulus Therapeutics Inc. (11)
- Erytech Pharma S.A. (11)
- CytomX Therapeutics, Inc. (11)
- KENT INTERNATIONAL HOLDINGS INC (10)
- NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (10)
- CURIS INC (10)
- PALATIN TECHNOLOGIES INC (10)
- Viracta Therapeutics, Inc. (10)
- Cullinan Oncology, Inc. (10)
- Syndax Pharmaceuticals Inc (10)
- Verastem, Inc. (10)
- Olema Pharmaceuticals, Inc. (10)
- AUTOIMMUNE INC (9)
- BIOCRYST PHARMACEUTICALS INC (9)
- APPLIED MOLECULAR EVOLUTION INC (9)
- FACET BIOTECH CORP (9)
- RIGEL PHARMACEUTICALS INC (9)
- Tobira Therapeutics, Inc. (9)
- IMMUNE DESIGN CORP. (9)
- Protagonist Therapeutics, Inc (9)
- POINT Biopharma Global Inc. (9)
- SIBIA NEUROSCIENCES INC (8)
- ESSENTIAL THERAPEUTICS INC (8)
- ATHEROGENICS INC (8)
- INSMED INC (8)
- Kura Oncology, Inc. (8)
- ESSA Pharma Inc. (8)
- AC Immune SA (8)
- GUILFORD PHARMACEUTICALS INC (7)
- IMMUNOGEN INC (7)
- GENOME THERAPEUTICS CORP (7)
- INVESTMENT 10 LLC (7)
- PHARMACOPEIA INC (7)
- NEKTAR THERAPEUTICS (7)
- GENAERA CORP (7)
- GTX INC /DE/ (7)
- Brickell Biotech, Inc. (7)
- OncoMed Pharmaceuticals Inc (7)
- Corvus Pharmaceuticals, Inc. (7)
- Molecular Templates, Inc. (7)
- ARIAD PHARMACEUTICALS INC (6)
- OSI PHARMACEUTICALS INC (6)
- Vitae Pharmaceuticals, Inc (6)
- Forte Biosciences, Inc. (6)
- Arcus Biosciences, Inc. (6)
- Principia Biopharma Inc. (6)
- BioLineRx Ltd. (6)
- Cidara Therapeutics, Inc. (6)
- Show More ...
Other (18)
D/A
Friday, 12/29/2023
Exempt (Private) Offering
D/A
Friday, 12/30/2022
Exempt (Private) Offering
D/A
Tuesday, 1/4/2022
Exempt (Private) Offering
D/A
Thursday, 1/7/2021
Exempt (Private) Offering
D/A
Friday, 1/10/2020
Exempt (Private) Offering
D/A
Friday, 1/11/2019
Exempt (Private) Offering
D/A
Friday, 12/8/2017
Exempt (Private) Offering
D/A
Wednesday, 9/21/2016
Exempt (Private) Offering
D/A
Wednesday, 11/12/2014
Exempt (Private) Offering
D/A
Friday, 11/8/2013
Exempt (Private) Offering
D/A
Thursday, 11/8/2012
Exempt (Private) Offering
D/A
Tuesday, 11/8/2011
Exempt (Private) Offering
D
Thursday, 10/21/2010
Exempt (Private) Offering
D/A
Thursday, 10/15/2009
Exempt (Private) Offering
CORRESP
Thursday, 3/5/2009
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 1/20/2009
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
REGDEX
Thursday, 10/2/2008
Form D (PDF)
REGDEX
Thursday, 2/13/2003
Form D (PDF)
Ownership (1672)
SC 13G/A
Wednesday, 2/14/2024
Crinetics Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
CytomX Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aravive, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Protagonist Therapeutics, Inc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Revolution Medicines, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Janux Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
IDEAYA Biosciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Jasper Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Verastem, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Elevation Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Eledon Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
iTeos Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cidara Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
4D Molecular Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Tyra Biosciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Molecular Templates, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
89bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Galmed Pharmaceuticals Ltd.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
GH Research PLC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ikena Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Kura Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ASLAN Pharmaceuticals Ltd: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
DELCATH SYSTEMS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Merus N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
LEXICON PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
AILERON THERAPEUTICS INC: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cullinan Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Centessa Pharmaceuticals plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
BIONOMICS LIMITED/FI: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Annexon, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Pyxis Oncology, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13D/A
Monday, 1/29/2024
Rain Oncology Inc.: Major Shareholders
4
Monday, 1/29/2024
Rain Oncology Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 1/29/2024
GLYCOMIMETICS INC: Major Shareholders
3
Friday, 1/26/2024
Allakos Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 1/18/2024
Allakos Inc.: Major Shareholders
SC 13G/A
Thursday, 1/18/2024
Allakos Inc.: Major Shareholders
SC 13G
Thursday, 1/18/2024
IMMUNIC, INC.: Major Shareholders
SC 13D/A
Tuesday, 1/16/2024
XOMA Corp: Major Shareholders
SC 13D/A
Tuesday, 1/9/2024
Kymera Therapeutics, Inc.: Major Shareholders
4
Tuesday, 1/9/2024
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 12/20/2023
Structure Therapeutics Inc.: Major Shareholders
SC 13D/A
Wednesday, 12/20/2023
POINT Biopharma Global Inc.: Major Shareholders
4
Wednesday, 12/20/2023
POINT Biopharma Global Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 12/19/2023
AC Immune SA: Major Shareholders
SC 13D/A
Monday, 12/18/2023
Rain Oncology Inc.: Major Shareholders
SC 13G
Monday, 12/4/2023
SAB Biotherapeutics, Inc.: Major Shareholders
SC 13D
Monday, 11/20/2023
MOLECULAR PARTNERS AG: Major Shareholders
SC 13D/A
Friday, 11/17/2023
Repare Therapeutics Inc.: Major Shareholders
4
Friday, 11/17/2023
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 11/13/2023
enGene Holdings Inc.: Major Shareholders
3
Monday, 11/13/2023
enGene Holdings Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 11/7/2023
MOLECULAR PARTNERS AG: Major Shareholders
4
Monday, 11/6/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 11/6/2023
POINT Biopharma Global Inc.: Major Shareholders
3
Monday, 11/6/2023
POINT Biopharma Global Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 11/3/2023
Repare Therapeutics Inc.: Major Shareholders
4
Friday, 11/3/2023
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 10/16/2023
Vistagen Therapeutics, Inc.: Major Shareholders
SC 13D/A
Monday, 9/25/2023
Inventiva S.A.: Major Shareholders
SC 13G
Monday, 9/18/2023
Mirum Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Thursday, 9/14/2023
Olema Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 9/14/2023
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 8/17/2023
Rain Oncology Inc.: Major Shareholders
SC 13D/A
Thursday, 8/17/2023
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Thursday, 8/10/2023
Forte Biosciences, Inc.: Major Shareholders
SC 13G
Thursday, 7/6/2023
Unicycive Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 6/30/2023
Revolution Medicines, Inc.: Major Shareholders
SC 13D/A
Friday, 6/30/2023
MoonLake Immunotherapeutics: Major Shareholders
SC 13D/A
Wednesday, 6/28/2023
CTI BIOPHARMA CORP: Major Shareholders
4
Wednesday, 6/28/2023
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 6/22/2023
DELCATH SYSTEMS, INC.: Major Shareholders
4
Wednesday, 6/21/2023
Olema Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Kymera Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
MoonLake Immunotherapeutics: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 6/5/2023
TScan Therapeutics, Inc.: Major Shareholders
SC 13G
Tuesday, 5/30/2023
Janux Therapeutics, Inc.: Major Shareholders
SC 13D
Monday, 5/22/2023
PIERIS PHARMACEUTICALS, INC.: Major Shareholders
3
Monday, 5/22/2023
PIERIS PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Friday, 5/19/2023
XOMA Corp: Statement of changes in beneficial ownership of securities
4
Friday, 5/12/2023
Structure Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/9/2023
Eledon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/7/2023
CTI BIOPHARMA CORP: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 3/24/2023
IDEAYA Biosciences, Inc.: Major Shareholders
SC 13G
Monday, 3/20/2023
Protagonist Therapeutics, Inc: Major Shareholders
SC 13G
Thursday, 3/16/2023
Aclaris Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 3/6/2023
ASLAN Pharmaceuticals Ltd: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
CONCERT PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Molecular Templates, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
AILERON THERAPEUTICS INC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Spero Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
RELMADA THERAPEUTICS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Kura Oncology, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Protagonist Therapeutics, Inc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Annexon, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
MOLECULAR PARTNERS AG: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Viracta Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
Prospectus (6)
SC TO-T/A
Friday, 3/27/2009
Third party tender offer statement
SC TO-T/A
Friday, 3/20/2009
Third party tender offer statement
SC TO-T/A
Monday, 3/9/2009
Third party tender offer statement
SC TO-T/A
Monday, 2/23/2009
Third party tender offer statement
SC TO-T/A
Friday, 2/6/2009
Third party tender offer statement
SC TO-C
Thursday, 1/15/2009
Written communication relating to an issuer or third party tender offer
Proxies (14)
DFAN14A
Monday, 3/23/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 3/20/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 3/13/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 3/13/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 3/12/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Tuesday, 3/10/2009
Definitive proxy statement in connection with contested solicitations
DFAN14A
Tuesday, 3/10/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 2/10/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 2/6/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PRRN14A
Thursday, 2/5/2009
Revised preliminary proxy statement filed by non-management
PRRN14A
Thursday, 1/29/2009
Revised preliminary proxy statement filed by non-management
DFAN14A
Thursday, 1/15/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PREC14A
Tuesday, 1/13/2009
Preliminary proxy statement in connection with contested solicitations
DFAN14A
Friday, 1/9/2009
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material